INTEREST 2021, 12-14 October 2021 (Virtual)
Day 3 of INTEREST 2021 is dedicated to the late Prof. Charles Boucher, who sadly passed away in February of this year.
Alongside the late Dr. Joep Lange, Charles founded the INTEREST conference in 2007 to bring together a multidisciplinary team of experts who could share knowledge and establish partnerships with the ultimate aim of improving the life quality of people living with HIV across the African continent.
The third day of this year's conference will feature memorial lectures
focusing on HIV epidemiological trends, the evolution of HIV treatment to
date and changes in how HIV healthcare services are being delivered in the
region. Delegates can expect to take part in interactive sessions exploring the
management of drug resistance, virological failure and the future of PrEP
in Africa.
Charles' love for teaching, particularly in regards to educating
young researchers, was well known. This final day of INTEREST 2021 features a
mentorship session, with the day specifically targeted towards young
investigators.
We invite you to join us in honouring Charles' memory at INTEREST 2021 and
contributing to the cross-disciplinary discussion on HIV treatment,
pathogenesis and prevention throughout Africa.The third day of this year's conference will feature memorial lectures
focusing on HIV epidemiological trends, the evolution of HIV treatment to
date and changes in how HIV healthcare services are being delivered in the
region. Delegates can expect to take part in interactive sessions exploring the
management of drug resistance, virological failure and the future of PrEP
in Africa.
Charles' love for teaching, particularly in regards to educating
young researchers, was well known. This final day of INTEREST 2021 features a
mentorship session, with the day specifically targeted towards young
investigators.
We invite you to join us in honouring Charles' memory at INTEREST 2021 and
contributing to the cross-disciplinary discussion on HIV treatment,
pathogenesis and prevention throughout Africa.
To register visit https://virology.eventsair.com/interest-2021/registration/Site/Register
Articles
Virtual Workshop: Recognition And Control Of Mtb Infected Cells: From Basics To The Clinic | 13 – 14June 2023
The Stop
TB Partnership Working Group on New TB Vaccines (WGNV) and the National
Institute for Allergy and Infectious Diseases (NIAID)are
co-hosting a workshop on the topic of Recognition and Control of Mtb
Infected Cells: From Basics to the Clinic. This workshop is intended to address
the need for correlates and to identify platforms that measure recognition or
control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for
Research and Development of New TB Vaccines and the Strategic Framework for
New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.
The overall goals of this workshop
are to:
- elucidate the mechanisms by
which the immune system recognizes the Mtb-infected cell
- explore the degree to which
such recognition can lead to control of the intracellular microbe, and
- discuss the translational
implications of these observations
The workshop format will be largely
discussion-based. Each session will have three short presentations that will
provide a high-level overview of key topics within the session theme, followed
by a discussion between the session chairs, speakers, and participants.
Click here
to view the programme and
speakers.
This workshop is free of charge and
open to any participants interested in this topic.
Ssi/Isid Infectious Diseases Research Fellowships | Deadline For Applications: 16 June 2023
The International Society for Infectious Diseases (ISID) and the Swiss
Society for Infectious Diseases (SSI) are inviting applications for their joint
Infectious Diseases Research Fellowship Program. The purpose of this programme
is to support infectious disease physicians and scientists from under-resourced
countries through multidisciplinary clinical and laboratory training at a
select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID
Fellowship programme is open to applicants who are 40 years or younger,
citizens and permanent residents of under-resourced countries or Eastern
Europe. The deadline for applications is 16 June 2023.
More information: https://na.eventscloud.com/eSites/748378/Homepage
Ethical Review Of Decentralized Clinical Trials (Dcts): Tools, Resources & Best Practices.
The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."
During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts
(Medable) and Leanne Madre (Medable) will present a framework, recommendations,
and tools organized around 3 DCT domains: People, Remote Data Collection, and
Data Oversight. Best practices for the ethical review, approval, and conduct of
DCTs will be provided.
Clinical trial stakeholders (IRB/ECs,
HRPP, sites, sponsors, investigators, and others) to register for the webinar here